[PDF] Top 20 Circulating procoagulant microparticles in cancer patients
Has 10000 "Circulating procoagulant microparticles in cancer patients" found on our website. Below are the top 20 most common "Circulating procoagulant microparticles in cancer patients".
Circulating procoagulant microparticles in cancer patients
... performed in cancer ...MPs in colorectal cancer patients compared to healthy controls and reported that TF positive MPs correlated with elevated D-dimer levels, which is a marker for ... Voir le document complet
15
Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture
... suggested in breast cancer as a good predictive model to screen potential alternative drug treatments in order to select those that are the most likely to be ...However, in order to inform ... Voir le document complet
10
“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
... lung cancer. Migration of circulating tumor cells (CTCs) into the blood stream is an early event that occurs during ...CTCs in complement to CT-scan in COPD patients without clinically ... Voir le document complet
8
A mesofluidic multiplex immunosensor for detection of circulating cytokeratin-positive cells in the blood of breast cancer patients
... Second, in addition to an increase of cell immobilization, the multiplex device offers a versatile tool easily grafted with various purified antibodies onto the four ...spiked in buffer containing an equal ... Voir le document complet
10
Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients
... Methods: In this study, we evaluated innovative circulating cardiac biomarkers during and after anthracycline-based neoadjuvant chemotherapy (NAC) in breast cancer ...10 circulating ... Voir le document complet
9
Profiling of circulating tumor DNA in plasma of non‐small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells
... p.T790M in the NCI‐H1975 positive cell line was confirmed using the NGS‐56G assay with a MAF around ...p.T790M in as few as five cells without spiking into total ...performed in order to validate the ... Voir le document complet
13
Technological Challenges and Future Issues for the Detection of Circulating MicroRNAs in Patients With Cancer
... analysis in days (Northern blot) to relatively short time-to-result quantitative RT-PCR and next-generation sequencing ...if circulating biopsies are envisioned ( Coenen-Stass et ...sequences in ... Voir le document complet
12
Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
... >0.01% in Exome Aggregation Consortium variants ...position in 29 negative ...alleles in 29 controls/sum of depth in 29 ...listed in Supplementary Table ... Voir le document complet
31
Circulating microRNAs as diagnostic markers in breast cancer patients and their deregulation under neoadjuvant chemotherapy
... Breast cancer is the leading cause of death by cancer among women and there is an urgent need to improve its diagnosis and ...implicated in breast cancer. In this article, we focus on ... Voir le document complet
1
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.
... development in order to be efficient and to further improve the life expectancy and/or the quality of life of breast cancer ...published in the past ...utility in different parts of the ... Voir le document complet
21
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
... increased in all patients, especially pSS patients with extra-glandular involvement who showed a signif- icantly decreased level of platelet ...reported in RA [44,45], we report for the first ... Voir le document complet
12
Microparticles and Fibrinolysis
... thrombosis in patients with cancer, the fibrinolytic potential of tum-MPs is associated with increased cellular invasiveness and ...prostate cancer cell lines through modi fication of adhesive ... Voir le document complet
7
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial
... Finally, in patients referred to surgery for LM resection, persistently detectable ctDNA levels before surgery was associated with short post-surgical OS, suggesting that LM were not fully responding to ... Voir le document complet
14
Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial
... conducted in more than 100 centers in France, plans to screen around 2640 patients in order to randomize (2:1; minimization method) 198 ctDNA positive ...patients. Patients aged ... Voir le document complet
12
Screening for Cancer in Patients with Glomerular Diseases
... THSD7A in glomerular subepithe- lial deposits, and are usually found with circulating antibodies in 70%–80% and 1%–5% of adults, ...reported in 20%–38% of malignancy-associated cases, which ... Voir le document complet
4
Cell-derived microparticles: a new challenge in neuroscience.
... Microparticles (MPs) are membrane fragments shed by cells activated by a variety of stimuli including serine proteases, inflammatory cytokines, growth factors and stress ...found in circulating ... Voir le document complet
29
eTumorType, an algorithm of discriminating cancer types for circulating tumor cells or cell-free DNAs in blood
... of cancer is becoming possible with the development of technologies on capturing circulating tumor cells (CTCs) and cell-free DNAs (cfDNAs) in blood, serum, and plasma [1–3] ...on cancer ... Voir le document complet
12
Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer.
... and cancer diagnosis and tumor progression in CRC ...and cancer patients showed that tumor- derived ccfDNA exhibits significant higher ccfDNA fragmentation (Mouliere et ...2011). In ... Voir le document complet
28
Impact of Epicatechin on the Procoagulant Activities of Microparticles
... interfere in cell-to-cell communication through various mechanisms, from the direct stimulation of target receptors to integration of surface receptors in a target ...role in pathological processes, ... Voir le document complet
14
Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery
... from cancer patients may provide important information regarding early detection, prognosis, treatment and relapse as well as improved mechanistic insight with respect to tumor invasion and ...this. ... Voir le document complet
31
Sujets connexes